Your browser doesn't support javascript.
loading
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.
Panowski, Siler H; Srinivasan, Surabhi; Tan, Nguyen; Tacheva-Grigorova, Silvia K; Smith, Bryan; Mak, Yvonne S L; Ning, Hongxiu; Villanueva, Jonathan; Wijewarnasuriya, Dinali; Lang, Shanshan; Melton, Zea; Ghosh, Adit; Dusseaux, Mathilde; Galetto, Roman; Heyen, Jonathan R; Sai, Tao; Van Blarcom, Thomas; Chaparro-Riggers, Javier; Sasu, Barbra J.
Afiliación
  • Panowski SH; Allogene Therapeutics, South San Francisco, California.
  • Srinivasan S; Allogene Therapeutics, South San Francisco, California.
  • Tan N; Allogene Therapeutics, South San Francisco, California.
  • Tacheva-Grigorova SK; Allogene Therapeutics, South San Francisco, California.
  • Smith B; Allogene Therapeutics, South San Francisco, California.
  • Mak YSL; Allogene Therapeutics, South San Francisco, California.
  • Ning H; Allogene Therapeutics, South San Francisco, California.
  • Villanueva J; Allogene Therapeutics, South San Francisco, California.
  • Wijewarnasuriya D; Allogene Therapeutics, South San Francisco, California.
  • Lang S; Allogene Therapeutics, South San Francisco, California.
  • Melton Z; Allogene Therapeutics, South San Francisco, California.
  • Ghosh A; Allogene Therapeutics, South San Francisco, California.
  • Dusseaux M; Cellectis, Paris, France.
  • Galetto R; Cellectis, Paris, France.
  • Heyen JR; Drug Safety Research and Development, Pfizer Worldwide Research and Development, La Jolla, California.
  • Sai T; Pfizer Worldwide Research and Development, South San Francisco, California.
  • Van Blarcom T; Allogene Therapeutics, South San Francisco, California.
  • Chaparro-Riggers J; Pfizer Worldwide Research and Development, South San Francisco, California.
  • Sasu BJ; Allogene Therapeutics, South San Francisco, California.
Cancer Res ; 82(14): 2610-2624, 2022 07 18.
Article en En | MEDLINE | ID: mdl-35294525

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Trasplante de Células Madre Hematopoyéticas / Neoplasias Renales Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Res Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Trasplante de Células Madre Hematopoyéticas / Neoplasias Renales Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Res Año: 2022 Tipo del documento: Article